Latest News

Sign up for our RSS Feed.
11 Aug 2014 Lee H. Latimer Joins NeurOp to Manage Its Chemistry Operations Read More
21 May 2014 NeurOp Selects NP10679 as Development Candidate for SAH Read More
Pipeline

Our most advanced compounds for major depression, neuropathic pain and ischemia demonstrate efficacy in animal models with no apparent toxicity at therapeutic doses. The chart below shows the progress towards our goal of placing a drug candidate in human clinical trials.

NR@B Program Click for more on Major Depression Click for more on Neruonal Protection Click for more on Neuropathic Pain